IL-20亚家族生物效应:癌症中的机制性见解和治疗前景
Valentina Maggisano1, Maria D'Amico2, Saveria Aquila2,3
1Department of Health Sciences, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy.
International journal of molecular sciences
|August 14, 2025
概括
介素-20 (IL-20) 细胞因子子家族影响瘤微环境 (TME),在癌症中发挥双重作用. 了解这些IL-20细胞因子是开发向癌症治疗的关键.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 介素-20 (IL-20) 细胞因子子家族,IL-10超级家族的一部分,包括IL-19,IL-20,IL-22,IL-24和IL-26.
- 这些细胞因子越来越多地被认为在癌症生物学中的重要作用,特别是在瘤微环境 (TME) 中.
研究的目的:
- 探索IL-20亚家族细胞因子在癌症中的复杂和上下文依赖的作用.
- 审查IL-20细胞因子和关键癌症特征之间的关系,包括扩散,血管新生,入侵,转移和TME调节.
- 突出针对IL-20信号通路在癌症治疗中的治疗潜力.
主要方法:
- 文献综述综合了目前关于癌症IL-20亚家族细胞因子的研究.
- 对研究IL-20细胞因子对癌细胞行为和TME的影响的分析.
- 检查针对IL-20受体的新兴治疗策略.
主要成果:
- IL-20亚系细胞因子表现出双重功能,既起到促瘤的作用 (例如,IL-22促进生长),又起到抗瘤的作用 (例如,IL-24诱导细胞死亡).
- 这些细胞因子显著影响TME内的巨细胞两极分化,影响炎症和免疫逃避.
- 介素-20受体对抗剂在抑制瘤生长和进展方面表现有前途.
结论:
- IL-20细胞因子子家族在癌症进展中发挥着多方面的作用,通过影响瘤细胞行为和TME的免疫格局.
- 进一步阐明控制IL-20细胞因子作用的特定机制对于优化向癌症治疗至关重要.
- 准IL-20信号通路是新型癌症治疗的有希望的策略.
更多相关视频
相关概念视频
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
Cytotoxic T Cells-mediated Immune Response
2.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.0K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K


